{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3093,"total_is_capped":false,"direct_labels_cover":8,"predictions_cover":3093,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"76d678ccd877","filters":{"topic":"Cystic Fibrosis Research Advances"}},"results":[{"id":"W2140868856","doi":"10.1056/nejmoa1105185","title":"A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":2174,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Children's Hospital of Pittsburgh; University of Alabama; National Center for Research Resources; University of Pennsylvania; Seattle Children's Research Institute; Vertex Pharmaceuticals; Case Western Reserve University; Medical Center, University of Pittsburgh; Cystic Fibrosis Foundation; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Imperial College London; University of Washington; Cystic Fibrosis Foundation Therapeutics; National Institute for Health and Care Research; University of Alabama at Birmingham; Children's Hospital of Philadelphia","keywords":"Potentiator; Cystic fibrosis; Medicine; Ivacaftor; Cystic fibrosis transmembrane conductance regulator; Mutation; Internal medicine; Genetics; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.009679022501706713,"gpt":0.2428851548663161,"spread":0.2332061323646094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000798874,0.0001097869,0.0003913763,0.0001877544,0.00003395962,0.000008243823,0.00008217132,0.00002909609,0.0001094094],"category_scores_gemma":[0.001114833,0.00004853488,0.00002872761,0.0002126662,0.0002887037,0.0001262919,0.00001699578,0.0002942997,0.000001719641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003612786,"about_ca_system_score_gemma":0.0001127746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000179382,"about_ca_topic_score_gemma":0.00003397526,"domain_scores_codex":[0.998589,0.0001112587,0.0003975895,0.0001015381,0.0006257076,0.0001748996],"domain_scores_gemma":[0.9988321,0.0003580945,0.0002219262,0.000121653,0.0002318695,0.0002343471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1037488,0.0004344083,0.6048113,0.0002918716,0.000346694,0.0007300611,0.01123069,0.00002378471,0.001177028,0.0004901858,0.002846468,0.2738688],"study_design_scores_gemma":[0.198362,0.00610751,0.7894717,0.001140561,0.0002573759,0.0006316954,0.0003454547,0.00007697769,0.0001278883,0.001114356,0.002284546,0.00007994501],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936441,0.001675784,0.001255133,0.002467554,0.0001352937,0.000317699,0.000001680142,0.000005540039,0.0004972568],"genre_scores_gemma":[0.9952677,0.00008681313,0.003913306,0.0002446884,0.0004010701,0.000002069468,0.000003684993,0.00001198643,0.00006861694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2737888,"threshold_uncertainty_score":0.1979195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2985405196","doi":"10.1056/nejmoa1908639","title":"Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":2116,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; Vertex Pharmaceuticals","keywords":"Ivacaftor; Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Placebo; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01751070533230126,"gpt":0.2934128043266692,"spread":0.2759020989943679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009620718,0.0003035893,0.001038204,0.00034511,0.00006035492,0.00002406323,0.0002648401,0.0001013789,0.0009128634],"category_scores_gemma":[0.001651075,0.0001799819,0.0001577937,0.0003180842,0.0001769736,0.0002384081,0.00003422729,0.0004784218,0.00002979099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00019772,"about_ca_system_score_gemma":0.0005009839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004228642,"about_ca_topic_score_gemma":0.000003261938,"domain_scores_codex":[0.99707,0.0000760902,0.0007679655,0.0003016704,0.001231689,0.0005525608],"domain_scores_gemma":[0.996567,0.001100805,0.0004687399,0.0003731646,0.000706561,0.0007837395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05443152,0.000741149,0.03309223,0.00155106,0.001028684,0.0005269978,0.0003550801,0.0003620209,0.6577967,0.0003894531,0.1048245,0.1449006],"study_design_scores_gemma":[0.166481,0.05017159,0.01250812,0.003479998,0.0007482013,0.004689098,0.0006344662,0.0005401232,0.008500072,0.0008192187,0.7509924,0.0004356877],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779491,0.003967176,0.01219277,0.00327871,0.0001352164,0.000944111,0.00001378889,0.00003590178,0.001483267],"genre_scores_gemma":[0.9579234,0.000144972,0.03181716,0.0005146944,0.005161721,0.00001038329,0.00002824768,0.00007083036,0.004328611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6492966,"threshold_uncertainty_score":0.9995213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1589654967","doi":"10.1056/nejmoa1409547","title":"Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1621,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Placebo; Randomization; Internal medicine; Clinical endpoint; Gastroenterology; Randomized controlled trial; Urology; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01897476457399061,"gpt":0.2954351084460771,"spread":0.2764603438720865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120524,0.0002308072,0.0008243301,0.000407713,0.00003491547,0.00001429024,0.0002013536,0.00007446345,0.00008077342],"category_scores_gemma":[0.003548099,0.0001369822,0.00007348942,0.0003812289,0.000164477,0.0002037228,0.00002871583,0.0004248282,0.000005841438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002518008,"about_ca_system_score_gemma":0.0005945798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008275193,"about_ca_topic_score_gemma":0.00002495429,"domain_scores_codex":[0.9972432,0.00008642126,0.0007327984,0.0002122242,0.001285649,0.0004396723],"domain_scores_gemma":[0.9969557,0.0005942726,0.0003367982,0.0002449869,0.0009024097,0.0009658397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1158891,0.001435807,0.5128533,0.0008155236,0.0005127687,0.001205549,0.00213716,0.0006621971,0.004086551,0.0001193016,0.1288335,0.2314494],"study_design_scores_gemma":[0.515966,0.05345188,0.2126375,0.004410731,0.000591951,0.00139525,0.0006349877,0.0003875828,0.0004522962,0.001270801,0.2083269,0.0004741499],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887456,0.002280929,0.004941729,0.002450079,0.0003205454,0.0007395523,0.00001622415,0.00001825374,0.0004870267],"genre_scores_gemma":[0.9824366,0.0000518363,0.01388983,0.0002744435,0.002749505,0.00000936594,0.00002866834,0.0000431488,0.0005165953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4000769,"threshold_uncertainty_score":0.5585971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2982296199","doi":"10.1016/s0140-6736(19)32597-8","title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1367,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Seattle Children's Research Institute; National Heart, Lung, and Blood Institute; Vertex Pharmaceuticals; National Institutes of Health; Cystic Fibrosis Foundation Therapeutics","keywords":"Ivacaftor; Cystic fibrosis; Regimen; Medicine; Double blind; Internal medicine; Mutation; Clinical trial; Genetics; Alternative medicine; Pathology; Biology; Cystic fibrosis transmembrane conductance regulator; Placebo","retraction":null,"screen_n_in":null,"score":{"opus":0.03018850664270445,"gpt":0.3330470684773987,"spread":0.3028585618346943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001216627,0.0002215177,0.0008142528,0.0000819363,0.0001932074,0.00005814002,0.0004498662,0.00008059142,0.00004545618],"category_scores_gemma":[0.0007771038,0.0001013457,0.000111707,0.0004762786,0.000273066,0.0001272077,0.0001015645,0.0003306902,0.000007557074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002101531,"about_ca_system_score_gemma":0.0003889791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001177565,"about_ca_topic_score_gemma":0.00002970038,"domain_scores_codex":[0.9979568,0.0001995175,0.0004783347,0.0003277715,0.0006260266,0.0004115884],"domain_scores_gemma":[0.9952562,0.00333973,0.0002949976,0.0008519945,0.0001773877,0.00007970501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9930167,0.0002317224,0.0002395619,0.0003331541,0.0001496334,0.000003421078,0.0004262385,0.0006927561,0.002138747,0.0003887229,0.001161118,0.001218215],"study_design_scores_gemma":[0.9763584,0.002633731,0.007160972,0.0004052114,0.0002758452,0.00006139517,0.000433616,0.008738463,0.0009530326,0.0001811822,0.00263354,0.0001646353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823526,0.0009287829,0.0008184579,0.003033273,0.00007498686,0.0124278,0.0000873247,0.00003166454,0.000245089],"genre_scores_gemma":[0.9969559,0.0001134847,0.0005416963,0.0001396366,0.0004267833,0.0009269901,0.00004594507,0.000035547,0.0008140606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01665833,"threshold_uncertainty_score":0.4132757,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062137132","doi":"10.1016/j.jpeds.2008.05.005","title":"Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report","year":2008,"lang":"en","type":"article","venue":"The Journal of Pediatrics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1091,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Cystic fibrosis; Medicine; Newborn screening; Cystic fibrosis transmembrane conductance regulator; Intensive care medicine; Sweat test; Gold standard (test); Pediatrics; Genetic testing; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05130790925385594,"gpt":0.3638563171446898,"spread":0.3125484078908339,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00171361,0.0002395035,0.0007324703,0.0003698878,0.000135866,0.00001547969,0.0002865405,0.0001211935,0.00005072177],"category_scores_gemma":[0.02153163,0.0001635367,0.0002703936,0.0008919192,0.0002519223,0.0002083055,0.00007030477,0.0003584179,0.000006068915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002108871,"about_ca_system_score_gemma":0.0007293887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002524798,"about_ca_topic_score_gemma":0.00003810708,"domain_scores_codex":[0.9961081,0.0001688019,0.001990844,0.0002159986,0.001095944,0.0004203011],"domain_scores_gemma":[0.9904071,0.004705907,0.001374172,0.0004457779,0.002898523,0.0001685277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0348939,0.003422295,0.6385443,0.01131153,0.0004090377,0.002676374,0.01159317,0.01171013,0.01549546,0.0001545166,0.2364114,0.03337782],"study_design_scores_gemma":[0.05404051,0.01995267,0.7608959,0.009097587,0.007633343,0.03531701,0.0121821,0.006048986,0.03405068,0.006479056,0.0519325,0.002369626],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722109,0.007671754,0.01478417,0.003700818,0.0004601385,0.001019869,0.00007697241,0.00001858875,0.00005682188],"genre_scores_gemma":[0.870545,0.009087699,0.1184416,0.0001740703,0.001431758,0.00004275416,0.00003544548,0.00005599109,0.0001856784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1844789,"threshold_uncertainty_score":0.9867104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975850958","doi":"10.1016/s2213-2600(19)30337-6","title":"The future of cystic fibrosis care: a global perspective","year":2019,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":961,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; BC Children's Hospital; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; Auckland Medical Research Foundation; National Heart, Lung, and Blood Institute; Health Research Council of New Zealand; Einstein Stiftung Berlin; National Health and Medical Research Council; European Commission; Ministerstvo Zdravotnictví Ceské Republiky; Bundesministerium für Bildung und Forschung; Ministerstvo Školství, Mládeže a Tělovýchovy; Queensland Health; University of Queensland; Deutsche Forschungsgemeinschaft; National Institutes of Health; U.S. Food and Drug Administration; National Institute for Health and Care Research; Legacy of Angels Foundation; Cystic Fibrosis Canada; Cystic Fibrosis Foundation; Genome Canada; Cystic Fibrosis Trust","keywords":"Cystic fibrosis; Life expectancy; Cystic fibrosis transmembrane conductance regulator; Disease; Population; Health care; Blueprint","retraction":null,"screen_n_in":null,"score":{"opus":0.02185742677756291,"gpt":0.3477663492933954,"spread":0.3259089225158325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008814104,0.0002099016,0.0006576795,0.00004689651,0.0001711809,0.00001338335,0.0005232068,0.0000764378,0.0002055711],"category_scores_gemma":[0.0009747837,0.00009275464,0.0001076701,0.0005906419,0.0008472488,0.00005736817,0.0001211708,0.0004259342,0.00009378055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003945118,"about_ca_system_score_gemma":0.0002957407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001101322,"about_ca_topic_score_gemma":0.0001082493,"domain_scores_codex":[0.9975996,0.0002309453,0.0003619122,0.0003145353,0.0009888642,0.0005041162],"domain_scores_gemma":[0.9972244,0.0007055367,0.0001728303,0.001194402,0.0005473492,0.0001554859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02669944,0.0002965574,0.1697945,0.003474114,0.001366758,0.0001840874,0.01361453,0.0001134432,0.1583228,0.2151078,0.29205,0.118976],"study_design_scores_gemma":[0.006056346,0.003510627,0.1582488,0.0007751936,0.0002012594,0.00006657147,0.02768838,0.00004730748,0.001414279,0.002296934,0.7994941,0.0002001033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5698307,0.2869652,0.000124771,0.06521421,0.001976585,0.003049613,0.0001295995,0.0001968326,0.0725125],"genre_scores_gemma":[0.9928429,0.0005645163,0.0002777781,0.001604561,0.004185978,0.00004732827,0.000007592167,0.00002626728,0.000443132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5074442,"threshold_uncertainty_score":0.3782424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2121996960","doi":"10.1056/nejmoa0909825","title":"Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":802,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration","keywords":"Cystic fibrosis; Medicine; Placebo; Ivacaftor; Cystic fibrosis transmembrane conductance regulator; Adverse effect; Gastroenterology; Internal medicine; Anesthesia; Urology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.004990658789322052,"gpt":0.2821076513827515,"spread":0.2771169925934295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002428712,0.0001281286,0.0005955264,0.0002225351,0.00003389778,0.000008777958,0.00009655378,0.00004541018,0.00007184454],"category_scores_gemma":[0.003557723,0.00005441491,0.0000440812,0.0002638843,0.000557352,0.0000898641,0.00001541996,0.0006481245,7.200617e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002185932,"about_ca_system_score_gemma":0.0001400915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002165547,"about_ca_topic_score_gemma":0.0001657036,"domain_scores_codex":[0.9984606,0.0002119248,0.0004018096,0.0001047741,0.0006444128,0.0001764909],"domain_scores_gemma":[0.9963347,0.002891518,0.0002494527,0.0001509345,0.0001471326,0.0002263139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09322127,0.0001551166,0.08638111,0.001335008,0.0003383401,0.00107831,0.009746496,0.0001156302,0.3170422,0.0003793419,0.003143708,0.4870634],"study_design_scores_gemma":[0.7116955,0.06295762,0.1379226,0.008049153,0.001837488,0.02486521,0.001811552,0.001766523,0.02845065,0.001247093,0.01902374,0.0003729099],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895585,0.001840521,0.0006063106,0.007088676,0.0001636611,0.0003170995,0.000002108851,0.000004511561,0.0004185925],"genre_scores_gemma":[0.9972659,0.0001188528,0.001590105,0.00008453972,0.0008092005,0.000003109478,0.000002469543,0.00001255919,0.0001133046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6184742,"threshold_uncertainty_score":0.4259184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2554519038","doi":"10.1183/13993003.01090-2016","title":"European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia","year":2016,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":703,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Imperial College London; National Institute for Health and Care Research; National Heart, Lung, and Blood Institute; AAIR Charity; Royal Brompton and Harefield NHS Foundation Trust; University Hospital Southampton NHS Foundation Trust; European Commission; European Respiratory Society","keywords":"Primary ciliary dyskinesia; Medicine; Dyskinesia; Respiratory system; Intensive care medicine; Pediatrics; Pathology; Internal medicine; Bronchiectasis; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.1236001364661994,"gpt":0.3629325092198889,"spread":0.2393323727536895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006388449,0.0003298862,0.0004937701,0.0001613824,0.0004459241,0.00007300261,0.0007503803,0.00004861227,0.0002497742],"category_scores_gemma":[0.005233013,0.0001694154,0.0006544222,0.0002848497,0.0005749288,0.0002885961,0.0002760794,0.0004672449,0.0001255839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001928842,"about_ca_system_score_gemma":0.0004488184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":9.744223e-7,"about_ca_topic_score_gemma":0.00000120092,"domain_scores_codex":[0.9956014,0.0009989281,0.001329172,0.0004453572,0.001015865,0.0006092623],"domain_scores_gemma":[0.9949895,0.001370214,0.000593001,0.0008665057,0.001761067,0.0004197322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006609099,0.0001563673,0.02105209,0.0001901327,0.0002786031,0.000241416,0.0001400523,0.00001495663,0.1472238,0.00004250362,0.519846,0.3101532],"study_design_scores_gemma":[0.003297704,0.0009301493,0.1655839,0.0007574045,0.0001127591,0.0001310997,0.0001225329,0.000007561763,0.005033158,0.00003408718,0.8237795,0.0002101823],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.729741,0.1186205,0.05449715,0.04250429,0.003369769,0.005212648,0.0005320325,0.0006261275,0.04489642],"genre_scores_gemma":[0.7658709,0.01381504,0.06629712,0.1085488,0.03363783,0.0002956851,0.00002386729,0.001846359,0.009664451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.309943,"threshold_uncertainty_score":0.6908562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990725675","doi":"10.1038/ng.2745","title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","year":2013,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":625,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Public Health Ontario; Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Science and Engineering Research Board; Cystic Fibrosis Foundation Therapeutics; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis transmembrane conductance regulator; Cystic fibrosis; Biology; Penetrance; Allele; Disease; Genetics; Genotype; Phenotype; Gene; Ivacaftor; Bioinformatics; Internal medicine; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.008891065869901502,"gpt":0.284383094917442,"spread":0.2754920290475405,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005293678,0.0001700898,0.0002826278,0.00005956658,0.00007572863,0.00003050939,0.000416685,0.0001542608,0.0001393553],"category_scores_gemma":[0.001486282,0.00009249911,0.00009865735,0.0005090575,0.0003273379,0.00006107894,0.00004556592,0.000704572,0.00001702628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004535618,"about_ca_system_score_gemma":0.0002084402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003320085,"about_ca_topic_score_gemma":0.00001889219,"domain_scores_codex":[0.9980431,0.0002010867,0.0003607031,0.0003141568,0.000722298,0.000358631],"domain_scores_gemma":[0.9978282,0.0008038597,0.00008532338,0.0009055136,0.000227631,0.0001494819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003556048,0.001953444,0.2098117,0.004328895,0.0003523225,0.0001861534,0.006439119,0.002768003,0.7139252,0.005084836,0.008984071,0.04261024],"study_design_scores_gemma":[0.0009938648,0.0001991299,0.9786124,0.000176403,0.00009094916,0.0000260323,0.0002556274,0.002555245,0.01299982,0.002547758,0.00141073,0.0001320954],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9702913,0.02422424,0.0001666264,0.003734994,0.0001331442,0.001145445,0.00008525628,0.0000162205,0.0002027484],"genre_scores_gemma":[0.9867091,0.0002234357,0.01227826,0.0005078602,0.00009387141,0.00008343221,0.00002568797,0.00002036576,0.00005803335],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7688007,"threshold_uncertainty_score":0.3772004,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3011807353","doi":"10.1136/thoraxjnl-2018-212463","title":"British Thoracic Society Guideline for bronchiectasis in adults","year":2018,"lang":"en","type":"article","venue":"Thorax","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":605,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Medical Research Council","keywords":"Bronchiectasis; Medicine; Guideline; Protocol (science); Clinical Practice; Radiology; Intensive care medicine; Family medicine; Pathology; Lung; Alternative medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0253434979374011,"gpt":0.3898730396736489,"spread":0.3645295417362479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005310123,0.0001136644,0.00027159,0.00005557121,0.00006347493,0.00002844048,0.0001247782,0.0000798692,0.0007381052],"category_scores_gemma":[0.0007362873,0.0001167384,0.0001312211,0.0003247242,0.0002044739,0.000102184,0.00006333806,0.0001516796,0.00006297081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000108675,"about_ca_system_score_gemma":0.000127391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004519387,"about_ca_topic_score_gemma":0.001164132,"domain_scores_codex":[0.9985371,0.00002893467,0.0003570787,0.0003326116,0.0003021064,0.0004421369],"domain_scores_gemma":[0.9990757,0.0001222246,0.00005128255,0.0002775497,0.0003256847,0.0001475967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002361727,0.0002857579,0.005370438,0.0006651474,0.00005741407,0.00003629701,0.0005800007,0.000003274657,0.01339964,0.00006004082,0.3217032,0.655477],"study_design_scores_gemma":[0.01144996,0.005160996,0.07421365,0.004149074,0.0001336481,0.0003671032,0.001551752,0.0258923,0.03689473,0.004284083,0.8349802,0.0009225297],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9605947,0.002816801,0.02253254,0.004772391,0.000324873,0.002253332,0.0001464076,0.0002353777,0.006323616],"genre_scores_gemma":[0.7453577,0.0002497807,0.2494038,0.001128744,0.001273086,0.0001493999,0.0001589802,0.00005790628,0.00222056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6545545,"threshold_uncertainty_score":0.8081734,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975909392","doi":"10.1016/j.jcf.2014.03.010","title":"European Cystic Fibrosis Society Standards of Care: Best Practice guidelines","year":2014,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Life expectancy; Best practice; Cystic fibrosis; Population; Family medicine; Pediatrics; Intensive care medicine; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04295695637302385,"gpt":0.4178732665236108,"spread":0.374916310150587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005772189,0.001093284,0.00624762,0.0006773614,0.0001992054,0.0001746967,0.001089151,0.0004945424,0.0002113391],"category_scores_gemma":[0.04414203,0.0007938428,0.003701413,0.001181849,0.0005364942,0.0005017892,0.0004034611,0.001873979,0.00009881674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315186,"about_ca_system_score_gemma":0.00409718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003462418,"about_ca_topic_score_gemma":0.00000272236,"domain_scores_codex":[0.9872925,0.001395854,0.005358309,0.000715884,0.004322397,0.0009150529],"domain_scores_gemma":[0.9749834,0.005113274,0.005689163,0.001269462,0.01209959,0.0008451014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001265167,0.0004017192,0.000004911857,0.1367564,0.002051735,0.0002659007,0.00035176,0.00006747844,0.0004669085,0.0000274482,0.08363929,0.7747013],"study_design_scores_gemma":[0.001526842,0.005417565,0.000008082269,0.1066484,0.01014427,0.002506097,0.0005369519,0.00003034424,0.00005370561,0.00001713791,0.8725813,0.0005293067],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000112908,0.9854023,0.009389264,0.0003818281,0.0008753308,0.0009912275,0.0009622969,0.0000435295,0.001942917],"genre_scores_gemma":[0.00006640855,0.7861992,0.2109839,0.0001173666,0.001915046,0.00001599414,0.0001022593,0.0002470069,0.0003528853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.788942,"threshold_uncertainty_score":0.9994512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159746250","doi":"10.1016/j.jcf.2008.03.009","title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","year":2008,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":591,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diagnostics; Hospital for Sick Children; Cystic Fibrosis Foundation; AOP Orphan; Genome Canada; Chiesi Farmaceutici","keywords":"Cystic fibrosis; Medicine; Interpretation (philosophy); Clinical Practice; Intensive care medicine; Mutation; Internal medicine; Family medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.08042228377408638,"gpt":0.4260154409714069,"spread":0.3455931571973205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002530807,0.0004935338,0.003719221,0.001693499,0.00008395337,0.00009969805,0.000302433,0.0003842115,0.00004333774],"category_scores_gemma":[0.06398587,0.0003080092,0.00144438,0.002090914,0.0005577139,0.000319096,0.00009240946,0.001531617,0.00001294897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003467598,"about_ca_system_score_gemma":0.000912762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006458537,"about_ca_topic_score_gemma":0.0000145758,"domain_scores_codex":[0.9915842,0.00217734,0.003958872,0.0004590256,0.001446696,0.0003738843],"domain_scores_gemma":[0.9497573,0.04431963,0.00388098,0.0005957529,0.001155744,0.000290614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007899604,0.001046941,0.0006621855,0.0135491,0.007156661,0.001192514,0.0006345675,0.0009977802,0.00007082427,0.0001050302,0.003803159,0.9628816],"study_design_scores_gemma":[0.005964985,0.01436115,0.02221567,0.1272029,0.05999444,0.01272336,0.0009283748,0.01366012,0.00004197791,0.0002178799,0.7413921,0.00129707],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005184577,0.9900046,0.002676064,0.0004658516,0.0002805579,0.001153393,0.0001451367,0.00001267258,0.00007717208],"genre_scores_gemma":[0.01232738,0.9387136,0.04847931,0.00009786613,0.0001930315,0.00002461086,0.00005242781,0.00006000986,0.00005177507],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9615846,"threshold_uncertainty_score":0.9999372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2337762305","doi":"10.1091/mbc.e14-04-0935","title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","year":2016,"lang":"en","type":"article","venue":"Molecular Biology of the Cell","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":590,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Tobacco-Related Disease Research Program; U.S. Public Health Service; National Institutes of Health; Cystic Fibrosis Trust; National Institute of General Medical Sciences; Cystic Fibrosis Foundation Therapeutics","keywords":"Ivacaftor; Cystic fibrosis transmembrane conductance regulator; Potentiator; Cystic fibrosis; Biology; ΔF508; Phenotype; Mutation; Genetics; Computational biology; Bioinformatics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01876071756754639,"gpt":0.3329115022905051,"spread":0.3141507847229588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000145836,0.0001184985,0.00030514,0.00008176296,0.00003209178,0.00000196748,0.0002632031,0.0001291073,0.0001509377],"category_scores_gemma":[0.000343334,0.00006712901,0.0001482375,0.0001550145,0.0006298344,0.00001983359,0.00007147725,0.0000913375,0.0000141372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003549584,"about_ca_system_score_gemma":0.0001057381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007051149,"about_ca_topic_score_gemma":0.000001226636,"domain_scores_codex":[0.9988247,0.0002884307,0.0003160808,0.0002486662,0.0001227399,0.0001993767],"domain_scores_gemma":[0.9987664,0.0004047106,0.0002127389,0.0004025205,0.0001504242,0.00006326812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003851259,0.0001326276,0.006791736,0.00003198883,0.00008062558,8.326998e-7,0.00007958399,0.000001399823,0.9892066,0.0009052103,0.0001037016,0.002280549],"study_design_scores_gemma":[0.002663623,0.000419911,0.00475162,0.00005672243,0.00007580194,0.000001823577,0.00003484012,0.00003779347,0.9731601,0.01715603,0.001571271,0.00007041846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9770085,0.0009451565,0.01899338,0.001789333,0.0004526807,0.0003805247,0.000176224,0.00001884268,0.0002353485],"genre_scores_gemma":[0.9958552,0.00005147072,0.003788822,0.00005435484,0.00006685807,0.00002900834,0.00006344741,0.00001493037,0.00007593614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01884666,"threshold_uncertainty_score":0.2737442,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2044826456","doi":"10.1126/science.1093941","title":"Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects","year":2004,"lang":"en","type":"article","venue":"Science","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":561,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences","keywords":"Curcumin; Cystic fibrosis transmembrane conductance regulator; ΔF508; Cystic fibrosis; Endoplasmic reticulum; Hamster; Transfection; Mutation; Chemistry; Molecular biology; Biology; Endocrinology; Cell biology; Gene; Pharmacology; Internal medicine; Biochemistry; Medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01121750691745472,"gpt":0.3057962313952892,"spread":0.2945787244778345,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003778711,0.0001176213,0.0002498437,0.0002386492,0.0001343676,0.00002761149,0.0002726303,0.00002707017,0.00007031054],"category_scores_gemma":[0.002688241,0.00009368901,0.00006231525,0.001357724,0.002262637,0.000211931,0.000116728,0.0001267595,0.00009990025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002070479,"about_ca_system_score_gemma":0.00120946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009121651,"about_ca_topic_score_gemma":0.000008732311,"domain_scores_codex":[0.9979514,0.00001506131,0.000216356,0.0003699285,0.0009697919,0.0004774977],"domain_scores_gemma":[0.9987849,0.0001519932,0.00008315918,0.0003750885,0.0002821011,0.0003227346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001587222,0.0001621063,0.006050055,0.0002007403,0.000008030684,0.00006634233,0.0002525169,0.0002495873,0.9887583,0.0009168289,0.0001274699,0.00304931],"study_design_scores_gemma":[0.002742137,0.001658315,0.06991804,0.001129782,0.00006374624,0.0004718254,0.0003845488,0.0004280607,0.9177195,0.002309024,0.002894295,0.0002807381],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990047,0.001139091,0.004680485,0.0002641632,0.0003656952,0.0004829047,0.00001403282,0.00005239621,0.002954212],"genre_scores_gemma":[0.9826031,0.00001584816,0.01711433,0.0001002473,0.00003288572,0.00001669903,0.000002323733,0.000007662379,0.0001069149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0710388,"threshold_uncertainty_score":0.8336778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068332307","doi":"10.1164/rccm.201111-2075oc","title":"The Lung Tissue Microbiome in Chronic Obstructive Pulmonary Disease","year":2012,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":553,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Canadian Institutes of Health Research; Tula Foundation","keywords":"COPD; Bronchoalveolar lavage; Medicine; Obstructive lung disease; Microbiome; Polymerase chain reaction; Lung; Respiratory disease; Firmicutes; Terminal restriction fragment length polymorphism; Microbiology; Microbiological culture; Pathology; Restriction fragment length polymorphism; Immunology; Gastroenterology; Internal medicine; 16S ribosomal RNA; Bacteria; Biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01303239300387092,"gpt":0.3486481814036685,"spread":0.3356157883997976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005911685,0.0001432275,0.0004187092,0.0001745745,0.0001170399,0.00001152231,0.0001226321,0.00002561359,0.00005176829],"category_scores_gemma":[0.002220034,0.00008299646,0.0000533747,0.0003442177,0.002641,0.0001839515,0.00004741102,0.0004784637,0.000002274882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003085392,"about_ca_system_score_gemma":0.0002904181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001332981,"about_ca_topic_score_gemma":0.000002454165,"domain_scores_codex":[0.9982845,0.0002176585,0.0004355067,0.000136154,0.0004642344,0.0004619635],"domain_scores_gemma":[0.9975788,0.0009788099,0.0001078839,0.0001856517,0.000321937,0.0008268883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003941255,0.0001915799,0.2669416,0.00106246,0.00008665956,0.002110606,0.0020071,0.000003106225,0.0865671,0.002325543,0.001246116,0.6335168],"study_design_scores_gemma":[0.001990006,0.007061129,0.8246511,0.001474102,0.0003317613,0.001201652,0.01914223,0.00002712554,0.001420477,0.0002898005,0.1421449,0.000265734],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.780471,0.2140481,0.0001530869,0.004614327,0.000260218,0.0001800032,0.000007843576,0.000007052922,0.0002583337],"genre_scores_gemma":[0.9978578,0.0003284334,0.0001549448,0.0005544804,0.001064282,0.00000722008,0.000001474373,0.00001535044,0.00001599076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6332511,"threshold_uncertainty_score":0.9730876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211144794","doi":"10.1038/nrdp.2015.10","title":"Cystic fibrosis","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":534,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Deafness and Other Communication Disorders; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration","keywords":"Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Disease; Medicine; Bioinformatics; Pathology; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05309794651600923,"gpt":0.4286600617102465,"spread":0.3755621151942373,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001156177,0.001068477,0.005408545,0.0004957555,0.00009209965,0.00007447323,0.0006437222,0.0008306136,0.0005065987],"category_scores_gemma":[0.006186857,0.000707273,0.002310901,0.001336907,0.0002266074,0.0001533045,0.0002730971,0.002775777,0.002076258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009402238,"about_ca_system_score_gemma":0.003804368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003085405,"about_ca_topic_score_gemma":5.719042e-7,"domain_scores_codex":[0.9944695,0.0007172374,0.001328727,0.001197988,0.001430429,0.0008561526],"domain_scores_gemma":[0.9943233,0.0003965129,0.0006534931,0.001846785,0.0003357627,0.002444202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008889924,0.0001102574,0.000002043877,0.1224348,0.0001928239,0.0001279736,0.000003349675,6.57706e-8,4.660347e-7,0.00004339219,0.06296986,0.8140261],"study_design_scores_gemma":[0.000357825,0.0001023985,0.000008156607,0.07986452,0.006563886,0.00007379638,0.000001925576,0.000002980864,2.003882e-7,0.00005038968,0.9124182,0.0005557599],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[8.85553e-8,0.9910096,0.000030496,0.0001150498,0.0005066138,0.006068652,0.000366572,0.0001533759,0.001749532],"genre_scores_gemma":[3.227463e-7,0.9878019,0.006442013,0.0002588178,0.0007387979,0.0008307812,0.001768971,0.0001880397,0.001970356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8494483,"threshold_uncertainty_score":0.9995378,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976507289","doi":"10.1172/jci24898","title":"Small-molecule correctors of defective  F508-CFTR cellular processing identified by high-throughput screening","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":534,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Eye Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Cystic Fibrosis Foundation; University of California, San Francisco; National Institutes of Health","keywords":"Cystic fibrosis transmembrane conductance regulator; Chemistry; Cystic fibrosis; Mutant; Chloride channel; Biochemistry; Molecular biology; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0881346237300916,"gpt":0.3969814860429774,"spread":0.3088468623128858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002265741,0.0001524253,0.0007127685,0.0001685414,0.00007016471,0.00004067804,0.0001675073,0.000158394,0.00005170641],"category_scores_gemma":[0.008246076,0.0001251879,0.000268931,0.0003649258,0.0004441832,0.0004436886,0.00004590665,0.0007396258,0.000009093831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000831393,"about_ca_system_score_gemma":0.0004508729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004034403,"about_ca_topic_score_gemma":0.00001359533,"domain_scores_codex":[0.9964551,0.0003009041,0.001944029,0.0002327521,0.0008268732,0.0002403175],"domain_scores_gemma":[0.9958936,0.0008799437,0.001669889,0.0001789594,0.000965934,0.0004116871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002139381,0.0007873685,0.1374225,0.0004974373,0.0003881617,0.00006725922,0.0006577029,0.0008768053,0.7397056,0.0001063416,0.009937529,0.1074139],"study_design_scores_gemma":[0.006127595,0.00286496,0.1243986,0.002520276,0.0004684781,0.00009592305,0.0003319144,0.008591925,0.8500054,0.001438911,0.002859865,0.0002961147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9573559,0.001166933,0.03953896,0.001308588,0.0002644882,0.0002247458,0.000004823156,0.00001685537,0.0001187488],"genre_scores_gemma":[0.9430222,0.00007126651,0.05567201,0.000295553,0.0007007657,0.000002755754,0.00001908146,0.00002486627,0.0001915387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1102998,"threshold_uncertainty_score":0.987192,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129639344","doi":"10.1164/rccm.201301-0059ci","title":"Primary Ciliary Dyskinesia. Recent Advances in Diagnostics, Genetics, and Characterization of Clinical Disease","year":2013,"lang":"en","type":"review","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":507,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Center for Research Resources; Hospital for Sick Children; Washington University in St. Louis; University of North Carolina at Chapel Hill; National Institutes of Health; National Heart, Lung, and Blood Institute; Seattle Children's Research Institute","keywords":"Primary ciliary dyskinesia; Medicine; Bronchiectasis; Cilium; Cystic fibrosis; Disease; Motile cilium; Pathology; Newborn screening; Kartagener Syndrome; Intensive care medicine; Lung; Pediatrics; Internal medicine; Genetics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04981169785676634,"gpt":0.4296066536023465,"spread":0.3797949557455802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0009442241,0.000345803,0.003378368,0.0004383499,0.00003307691,0.00001168947,0.0001593576,0.0001194278,0.00006109637],"category_scores_gemma":[0.01005707,0.0002290551,0.0001857529,0.0004018517,0.003036459,0.000182235,0.00009379084,0.0008673843,0.000001110137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008216457,"about_ca_system_score_gemma":0.0008408504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002496394,"about_ca_topic_score_gemma":0.000001309555,"domain_scores_codex":[0.995594,0.000710634,0.002250067,0.0003821688,0.0007571119,0.0003060158],"domain_scores_gemma":[0.9941062,0.002784662,0.0008575839,0.0002877026,0.0009798808,0.0009840213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003243784,0.0001126492,0.01148512,0.02000888,0.00003999265,0.0003569599,0.0000466905,3.806423e-8,0.00001711071,0.000024398,0.00005167341,0.9675321],"study_design_scores_gemma":[0.001152139,0.006786086,0.03467799,0.03264668,0.001141469,0.0001391989,0.000369755,0.000001434136,0.000002326134,0.00003406403,0.9228326,0.0002162578],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009036161,0.9894419,0.00008798229,0.0005083985,0.0002887211,0.0005306341,0.00005599278,0.000005275006,0.00004495806],"genre_scores_gemma":[0.001973755,0.9960927,0.0004322579,0.0004973545,0.0008969622,0.00002076241,0.00004527616,0.0000366281,0.000004263079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9673159,"threshold_uncertainty_score":0.9996767,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095687634","doi":"10.1164/rccm.201301-0153oc","title":"Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a <i>G551D</i> Mutation","year":2013,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Placebo; Internal medicine; Cystic fibrosis transmembrane conductance regulator; Pulmonary function testing; Adverse effect; Gastroenterology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.00817608707534317,"gpt":0.2910546343982897,"spread":0.2828785473229465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002415274,0.0001367218,0.0005831735,0.0002654057,0.00003205052,0.000009954099,0.00006405383,0.00002563569,0.00003797226],"category_scores_gemma":[0.001538039,0.00008520756,0.00002064999,0.0004231099,0.001084168,0.0001379069,0.00002434747,0.0002400519,8.278459e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005848529,"about_ca_system_score_gemma":0.0001120769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000099687,"about_ca_topic_score_gemma":0.0000152073,"domain_scores_codex":[0.9983836,0.0001344994,0.000442941,0.0001801858,0.0006284668,0.0002302565],"domain_scores_gemma":[0.9979413,0.0006947134,0.0001341683,0.0001305606,0.0006048505,0.000494435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0213664,0.0002903518,0.7705638,0.0007499019,0.00008223102,0.0004043584,0.003053664,0.00002272164,0.008719902,0.00005956019,0.0003140091,0.194373],"study_design_scores_gemma":[0.006702075,0.04185003,0.9438441,0.001814023,0.0001128264,0.00007958031,0.00483319,0.000002627807,0.0002248421,0.000009569111,0.0004288009,0.0000983624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977883,0.0007423478,0.0003632588,0.0006790806,0.00001432653,0.0003645857,0.000006433213,0.00000464619,0.00003700277],"genre_scores_gemma":[0.9956234,0.00001263776,0.003635526,0.0006331326,0.00006495133,0.00000894141,0.000002373827,0.0000161049,0.000002986482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1942747,"threshold_uncertainty_score":0.3994662,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051836609","doi":"10.1164/rccm.201404-0703oc","title":"Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis","year":2014,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":498,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Ivacaftor; Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Mucociliary clearance; Internal medicine; Gastroenterology; Potentiator; Population; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.01825005310589579,"gpt":0.3340414673916735,"spread":0.3157914142857777,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.002050141,0.0003216484,0.001622574,0.0003156798,0.0001049166,0.00001483158,0.0003845311,0.0001423579,0.0001347794],"category_scores_gemma":[0.01516743,0.0002014525,0.0003010358,0.0008294974,0.003669344,0.0001647661,0.00007281604,0.0009762374,0.000002930034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000101235,"about_ca_system_score_gemma":0.0003764637,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003220914,"about_ca_topic_score_gemma":0.000008607944,"domain_scores_codex":[0.9949191,0.001098037,0.001743902,0.0004196501,0.001287273,0.0005320474],"domain_scores_gemma":[0.9931761,0.004083913,0.0005187648,0.0005239985,0.0009149039,0.0007823281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01412333,0.0009683779,0.1230217,0.005480057,0.0004460851,0.0006010541,0.001863127,0.00002561089,0.6949205,0.007178197,0.001275293,0.1500967],"study_design_scores_gemma":[0.03592926,0.108792,0.731385,0.02230009,0.003535004,0.001821765,0.02355047,0.001179049,0.03536744,0.004279311,0.03011621,0.001744413],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868984,0.006380502,0.002866491,0.002931386,0.000385952,0.0003569764,0.00004195431,0.00001735978,0.000121037],"genre_scores_gemma":[0.9939646,0.0001248065,0.003820637,0.00145918,0.0005633349,0.000009583136,0.000003585754,0.00004008335,0.00001415581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6595531,"threshold_uncertainty_score":0.9990421,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098000470","doi":"10.1128/jcm.38.9.3165-3173.2000","title":"DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Microbiology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":497,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"","keywords":"Burkholderia cepacia complex; Biology; Burkholderia; Microbiology; Restriction fragment length polymorphism; Burkholderia cenocepacia; 16S ribosomal RNA; Genetics; Polymerase chain reaction; Gene; Bacteria","retraction":null,"screen_n_in":null,"score":{"opus":0.0847588129003253,"gpt":0.3727122903807585,"spread":0.2879534774804332,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00450322,0.0008619122,0.003501864,0.0005432802,0.0003175911,0.0001440041,0.0006237816,0.000877863,0.0007062005],"category_scores_gemma":[0.006286182,0.0007385308,0.0008584869,0.0005409429,0.002728812,0.0004220119,0.0001722022,0.00107482,0.0000155173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001435542,"about_ca_system_score_gemma":0.0006513593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005261446,"about_ca_topic_score_gemma":0.00004999099,"domain_scores_codex":[0.9905873,0.001007661,0.005425505,0.001335139,0.000454078,0.001190329],"domain_scores_gemma":[0.9887595,0.005719887,0.002476519,0.001007303,0.001121244,0.0009155146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.007311575,0.001549817,0.006886451,0.001023679,0.0007302008,0.00006024637,0.0005064684,0.0001794038,0.9633932,0.0001146474,0.002074102,0.0161702],"study_design_scores_gemma":[0.08812769,0.02099026,0.4704342,0.003008785,0.004083876,0.003808926,0.002883715,0.008911076,0.2655074,0.003216609,0.1254666,0.003560728],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860109,0.004004292,0.003662891,0.00213858,0.0008210656,0.002559672,0.0006708599,0.00006025213,0.00007145754],"genre_scores_gemma":[0.9783251,0.002144372,0.01758917,0.0004410848,0.000715819,0.00008850983,0.0003635215,0.0001348532,0.0001975165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6978858,"threshold_uncertainty_score":0.9999852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2170032136","doi":"10.1136/thoraxjnl-2011-200393","title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation","year":2011,"lang":"en","type":"article","venue":"Thorax","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":496,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; University of Colorado Denver; National Institutes of Health; National Center for Research Resources; Georgia Clinical and Translational Science Alliance; Vertex Pharmaceuticals; University of Washington; Nationwide Children's Hospital; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Harvard Catalyst; Case Western Reserve University; Washington University in St. Louis; Harvard University; Hospital for Sick Children; Northwestern University; Cystic Fibrosis Foundation Therapeutics; Children's Hospital of Philadelphia","keywords":"Cystic fibrosis; Medicine; Placebo; Cystic fibrosis transmembrane conductance regulator; Tolerability; Pharmacodynamics; Adverse effect; Pharmacokinetics; Sweat test; Internal medicine; Discontinuation; Gastroenterology; Sweat gland; Pharmacology; Pathology; SWEAT","retraction":null,"screen_n_in":null,"score":{"opus":0.06009892135269617,"gpt":0.3495034684645923,"spread":0.2894045471118961,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007179359,0.0001782774,0.0004341716,0.0002100538,0.00008048582,0.00001307386,0.0002062759,0.00004837988,0.00002165334],"category_scores_gemma":[0.001090658,0.0001196176,0.00004788959,0.0005928997,0.0003425453,0.0001774177,0.00003935177,0.0001667176,0.00000263925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006942386,"about_ca_system_score_gemma":0.0002867057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001336374,"about_ca_topic_score_gemma":0.002012148,"domain_scores_codex":[0.9979962,0.0001922834,0.000579582,0.0003275102,0.0006249191,0.0002795077],"domain_scores_gemma":[0.9975125,0.001137605,0.0002920731,0.0004760248,0.0004339542,0.0001478866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.2382745,0.0333672,0.06127907,0.002857286,0.001138877,0.0006300591,0.105223,0.003947994,0.5179898,0.0007332786,0.002254117,0.03230483],"study_design_scores_gemma":[0.1260287,0.1305902,0.4499571,0.002538083,0.00153173,0.0005470493,0.0414894,0.05235224,0.1905021,0.002657298,0.0006049949,0.001201109],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947561,0.0001616441,0.002236913,0.00007891504,0.00006910067,0.002321986,0.0002222848,0.00002826331,0.0001247792],"genre_scores_gemma":[0.9880978,0.000004894025,0.01136297,0.00002852421,0.00005022899,0.0002115135,0.0001537884,0.00002899241,0.00006125976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.388678,"threshold_uncertainty_score":0.4877864,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979451256","doi":"10.1056/nejmoa051469","title":"Genetic Modifiers of Lung Disease in Cystic Fibrosis","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":495,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Hospital for Sick Children","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Cystic fibrosis; Medicine; Genotype; Cystic fibrosis transmembrane conductance regulator; Odds ratio; Gastroenterology; Internal medicine; Allele; Disease; Respiratory disease; Lung; Pathology; Immunology; Genetics; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0128989920890459,"gpt":0.305832462110722,"spread":0.2929334700216761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006181303,0.0001363585,0.0005680996,0.0004616083,0.00001719675,0.000004045275,0.0001482417,0.00003822061,0.0004346346],"category_scores_gemma":[0.002205715,0.00009087035,0.00008369685,0.0003134952,0.0001744041,0.0001033276,0.00002216394,0.0003403648,0.00000342545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001267085,"about_ca_system_score_gemma":0.0003726825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009239171,"about_ca_topic_score_gemma":0.00003001555,"domain_scores_codex":[0.997902,0.00008726618,0.0007710051,0.0001282257,0.0008461082,0.0002653544],"domain_scores_gemma":[0.9982117,0.0004180107,0.000261345,0.000203055,0.0001995822,0.0007063309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01388453,0.00041961,0.4100187,0.0008838383,0.0001869579,0.001311658,0.001821906,0.009197559,0.03660167,0.00009745714,0.01395122,0.5116249],"study_design_scores_gemma":[0.1209233,0.004017408,0.7916555,0.006366622,0.0006531015,0.001073827,0.0002422628,0.01502795,0.001624357,0.001194074,0.05694831,0.000273309],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700254,0.01747042,0.002605495,0.009087476,0.0001991314,0.000229355,0.000005258642,0.000007001548,0.0003704125],"genre_scores_gemma":[0.9891131,0.0009323622,0.007320244,0.0001469276,0.002205728,0.000002212517,0.000002766229,0.00001625712,0.000260438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5113516,"threshold_uncertainty_score":0.4758944,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138833643","doi":"10.1136/thx.2007.086041","title":"Patient adherence in COPD","year":2008,"lang":"en","type":"review","venue":"Thorax","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":494,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; McGill University","keywords":"Medicine; Intensive care medicine; Disease; COPD; Quality of life (healthcare); Disease management; Adverse effect; Pulmonary disease; Health care; MEDLINE; Physical therapy; Nursing; Psychiatry; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08155612072110872,"gpt":0.4217160293691869,"spread":0.3401599086480782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008570634,0.0002536184,0.001385446,0.0002306217,0.00002401027,0.000009145044,0.0001402448,0.000151308,0.0003137543],"category_scores_gemma":[0.0003882822,0.000184518,0.0002078269,0.0004937659,0.0001044402,0.00003743935,0.00009887824,0.000567934,0.0008458354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002500805,"about_ca_system_score_gemma":0.0005879726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003751701,"about_ca_topic_score_gemma":0.00001659298,"domain_scores_codex":[0.9982581,0.0001215795,0.0004722829,0.0003432274,0.0004487986,0.0003560538],"domain_scores_gemma":[0.9989796,0.000225471,0.0001246046,0.0004495338,0.00005381564,0.0001670204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002029449,0.00006715591,0.000009646687,0.008302897,0.00001796003,0.0003692499,0.00003255152,1.136059e-7,7.716044e-7,0.00001233196,0.005135684,0.9860314],"study_design_scores_gemma":[0.0001770701,0.000337129,0.00002373463,0.0255745,0.00004492195,0.0002997394,0.000008703171,0.000002370835,0.000001924537,0.0000153851,0.9733657,0.0001488489],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001770773,0.9924981,0.000007111033,0.00001452903,0.0001127416,0.001147453,0.00002714923,0.00003628226,0.006138932],"genre_scores_gemma":[0.0000117334,0.9969443,0.001344329,0.000024191,0.00008711945,0.0001853058,0.00009191893,0.00003824574,0.001272866],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9858825,"threshold_uncertainty_score":0.9999321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2808504398","doi":"10.1164/rccm.201805-0819st","title":"Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline","year":2018,"lang":"en","type":"review","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":488,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Children's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Primary ciliary dyskinesia; Guideline; Clinical Practice; Dyskinesia; Primary care; Intensive care medicine; Family medicine; Bronchiectasis; Pathology; Internal medicine; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.09871856943004736,"gpt":0.5122769575252409,"spread":0.4135583880951936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.005218956,0.000703394,0.006665168,0.0004571044,0.0001414499,0.00002675675,0.0005564265,0.0002638754,0.0001182795],"category_scores_gemma":[0.02595663,0.0004703072,0.001147034,0.001291063,0.0122134,0.0003626727,0.0002041689,0.002111416,0.000004785339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002842931,"about_ca_system_score_gemma":0.002795424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005456521,"about_ca_topic_score_gemma":0.000006661668,"domain_scores_codex":[0.9897497,0.002302238,0.00441579,0.0007758122,0.002098619,0.0006578782],"domain_scores_gemma":[0.9816287,0.008628244,0.00274462,0.0008235727,0.004656976,0.001517876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001209358,0.0004621074,0.000602206,0.01090708,0.0004384252,0.0005740897,0.0002260823,8.828655e-8,0.000005391677,0.00002123871,0.008621196,0.9769328],"study_design_scores_gemma":[0.0008754901,0.03833396,0.0004034755,0.01683002,0.005641077,0.001208356,0.005285388,0.000002184382,0.000004275179,0.0000119376,0.9310443,0.000359535],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00120138,0.9947174,0.001105903,0.001524222,0.0004707832,0.0005551731,0.00009419906,0.00002688976,0.0003041182],"genre_scores_gemma":[0.0007913037,0.9529473,0.03515775,0.004713132,0.006189522,0.00002745449,0.00005726443,0.0001097315,0.000006521736],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9765732,"threshold_uncertainty_score":0.9997749,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975572445","doi":"10.1016/j.jcf.2015.03.003","title":"Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy","year":2015,"lang":"en","type":"review","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cystic Fibrosis Canada; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Inflammation; Immunology; Neutrophil elastase; Lung; Pathogenesis; Bronchiectasis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03433526322834295,"gpt":0.3569100860143668,"spread":0.3225748227860238,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001807815,0.0007528933,0.003533035,0.001457222,0.00008610628,0.0001633023,0.0004044948,0.0003835681,0.0001219251],"category_scores_gemma":[0.003151294,0.0005471401,0.0007633367,0.001085542,0.0002716844,0.0004576519,0.0001501697,0.0009289078,0.00002655963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008044179,"about_ca_system_score_gemma":0.002086499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001160224,"about_ca_topic_score_gemma":0.00000236277,"domain_scores_codex":[0.9941176,0.0006480752,0.002345633,0.0005314028,0.001696487,0.0006608267],"domain_scores_gemma":[0.9945106,0.0015447,0.001536338,0.0006126218,0.000719196,0.001076548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001401784,0.0001413965,0.0005219403,0.03398411,0.0002924224,0.0004591652,0.00009025088,0.00001800063,0.0002783305,0.00001538397,0.001193655,0.9616036],"study_design_scores_gemma":[0.002583655,0.001036079,0.002543148,0.06589756,0.00216872,0.0009371066,0.00004070782,0.0002438419,0.00001944468,0.0002607349,0.9236851,0.0005839214],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00097232,0.9964069,0.0004905526,0.0001420245,0.0003221786,0.001396814,0.0001915461,0.00002856704,0.00004912302],"genre_scores_gemma":[0.0003681795,0.9877529,0.0104469,0.00001770618,0.0008168345,0.0001416769,0.0001050135,0.0001384208,0.0002123797],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9610196,"threshold_uncertainty_score":0.999698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016504972","doi":"10.1097/gim.0b013e3181a53562","title":"Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome","year":2009,"lang":"en","type":"review","venue":"Genetics in Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":482,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Primary ciliary dyskinesia; Cilium; Ciliopathies; Dynein; Bronchiectasis; Intraflagellar transport; Motile cilium; Heterotaxy; Situs inversus; Kartagener Syndrome; Mucociliary clearance; Biology; Bardet–Biedl syndrome; Medicine; Pathology; Genetics; Anatomy; Internal medicine; Lung; Flagellum; Microtubule; Heart disease","retraction":null,"screen_n_in":null,"score":{"opus":0.07863788039231019,"gpt":0.4255068843645594,"spread":0.3468690039722492,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001124037,0.0006068817,0.00506358,0.0007869039,0.00002955941,0.000007501794,0.000391736,0.0005478126,0.0001490411],"category_scores_gemma":[0.001240512,0.0004409739,0.0002875826,0.0008208629,0.001218613,0.0000242581,0.0002201342,0.001094937,0.00002044847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001386081,"about_ca_system_score_gemma":0.0008916516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001477676,"about_ca_topic_score_gemma":0.00001452464,"domain_scores_codex":[0.9945651,0.0004126335,0.002410121,0.0009282659,0.001088447,0.0005954517],"domain_scores_gemma":[0.9967697,0.0009669712,0.0004877386,0.001126996,0.0001652585,0.0004833761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004666372,0.0001776099,0.001390674,0.02740331,0.0001398366,0.002017925,0.0000222285,0.000001327052,0.00002474861,0.00002967004,0.0008488231,0.9678972],"study_design_scores_gemma":[0.00278717,0.003533901,0.07546651,0.05721435,0.001743941,0.004039675,0.00001458473,0.00002528519,0.000003149611,0.0006384024,0.8540521,0.000480975],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001544075,0.993651,0.00007945621,0.0002047418,0.0003329891,0.001662994,0.00002118293,0.0000281135,0.00247548],"genre_scores_gemma":[0.0003855758,0.9876524,0.01052538,0.0001971016,0.0006332238,0.00004688952,0.0001307039,0.00008737833,0.0003413916],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9674162,"threshold_uncertainty_score":0.9998042,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990670389","doi":"10.1159/000029497","title":"Genotype and Phenotype in Cystic Fibrosis","year":2000,"lang":"en","type":"review","venue":"Respiration","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":482,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Genotype; Genetics; Allele; Phenotype; Mutation; Biology; Meconium Ileus; Apical membrane; Gene; Medicine; Epithelium","retraction":null,"screen_n_in":null,"score":{"opus":0.04662821051745368,"gpt":0.370547954390504,"spread":0.3239197438730503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002487342,0.00024485,0.0009847567,0.000399434,0.00004014962,0.00004284231,0.00007349912,0.0002205405,0.0003470397],"category_scores_gemma":[0.0004256078,0.0001977,0.0001038615,0.0004801722,0.00006113854,0.00009448991,0.00003580327,0.0003463894,0.0002350939],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001988673,"about_ca_system_score_gemma":0.0003323956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003775772,"about_ca_topic_score_gemma":0.00003117307,"domain_scores_codex":[0.9983687,0.0001523478,0.0004952385,0.0004021814,0.0003123526,0.0002691177],"domain_scores_gemma":[0.9991591,0.0002525169,0.0001072868,0.0003164668,0.00004069968,0.0001239031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006871749,0.00002985628,0.00002155835,0.01055687,0.00001791694,0.00002335149,0.00001662488,0.000001832216,0.00001010115,0.00002972809,0.0002252584,0.9889982],"study_design_scores_gemma":[0.0003149461,0.0002754376,0.0001651028,0.009130212,0.0001879217,0.00003169635,0.000001664709,0.0000303538,0.000002188619,0.00005759075,0.9896429,0.0001599441],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009086083,0.9974816,0.0000327936,0.00002899019,0.00004145874,0.001072567,0.0000439168,0.00003413638,0.00117364],"genre_scores_gemma":[0.00002706643,0.9976982,0.001198925,0.00003171632,0.000167151,0.0001641869,0.0003014613,0.0000335245,0.0003777467],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9894177,"threshold_uncertainty_score":0.8061971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015160508","doi":"10.1097/01.gim.0000139506.11694.7c","title":"Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel","year":2004,"lang":"en","type":"article","venue":"Genetics in Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Medical genetics; Cystic fibrosis; Medicine; Mutation; Carrier testing; Genetics; Population; Internal medicine; Biology; Prenatal diagnosis; Environmental health; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.03487385100144773,"gpt":0.3618580589230443,"spread":0.3269842079215966,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009851224,0.0002149962,0.0008361082,0.0004839018,0.00003671544,0.00000252176,0.000251522,0.0001510224,0.000148908],"category_scores_gemma":[0.003081006,0.000182284,0.0000742642,0.001162069,0.0007906786,0.00003498699,0.00009313502,0.0003123057,0.000002154424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001683724,"about_ca_system_score_gemma":0.0003066574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009653373,"about_ca_topic_score_gemma":0.000182502,"domain_scores_codex":[0.9956514,0.0001231078,0.001112624,0.0003696091,0.002377208,0.0003660451],"domain_scores_gemma":[0.99808,0.0003477465,0.0003729559,0.0005030129,0.0003595503,0.0003367655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003757414,0.001268988,0.3187305,0.005216845,0.0003363668,0.0008461887,0.003717915,0.0441012,0.1755863,0.001570827,0.001982029,0.4428855],"study_design_scores_gemma":[0.01801317,0.01010065,0.8895033,0.01127674,0.0004872164,0.0003880604,0.003823216,0.02009659,0.03878397,0.003158908,0.003772809,0.0005953662],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9648018,0.006426327,0.02514148,0.002554535,0.0001440976,0.0007342735,0.0001027251,0.00002214366,0.00007260463],"genre_scores_gemma":[0.9385508,0.00156981,0.05935038,0.0001098218,0.0001938779,0.000007554259,0.000155557,0.00003476259,0.00002747618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5707728,"threshold_uncertainty_score":0.7433324,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147898933","doi":"10.1073/pnas.0606756104","title":"Selection for <i>Staphylococcus aureus</i> small-colony variants due to growth in the presence of <i>Pseudomonas aeruginosa</i>","year":2006,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; University of Washington; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Staphylococcus aureus; Pseudomonas aeruginosa; Microbiology; Tobramycin; Biology; Methicillin-resistant Staphylococcus aureus; Antibiotics; Leukocidin; Population; Staphylococcal infections; Aminoglycoside; Bacteria; Medicine; Genetics; Gentamicin","retraction":null,"screen_n_in":null,"score":{"opus":0.02931426515606993,"gpt":0.3142490462718586,"spread":0.2849347811157887,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002176496,0.0001022921,0.0002314643,0.0002698082,0.000133034,0.00001926955,0.0007777327,0.00006598605,0.000003610359],"category_scores_gemma":[0.002761569,0.00006033158,0.00008142958,0.001801858,0.0005959684,0.0002591953,0.000092747,0.0001787579,4.685333e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004972511,"about_ca_system_score_gemma":0.0001019756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000115692,"about_ca_topic_score_gemma":0.000003993362,"domain_scores_codex":[0.9975887,0.00001397269,0.0004243961,0.0002715122,0.001448674,0.0002527688],"domain_scores_gemma":[0.9983054,0.0006565162,0.0003113972,0.00001325694,0.0006757108,0.00003765601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002115239,0.0001727369,0.02076775,0.0002681951,0.000009758599,2.313211e-8,0.0002050434,0.0001827357,0.9434301,0.03059574,0.003998012,0.0001583822],"study_design_scores_gemma":[0.000541717,0.0003393807,0.2517568,0.0002480038,0.00001731876,0.0000166598,0.0001762988,0.001060989,0.6951085,0.05027978,0.000380138,0.00007443014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845712,0.0001199073,0.00003731572,0.01070849,0.00001847061,0.001274865,0.00003487591,0.0000089285,0.003225948],"genre_scores_gemma":[0.9905047,0.000009642873,0.008845418,0.0003324179,0.0001078443,0.0001015583,3.336962e-7,0.000004722257,0.00009335842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2483216,"threshold_uncertainty_score":0.3306056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064659330","doi":"10.1161/circulationaha.106.649038","title":"Congenital Heart Disease and Other Heterotaxic Defects in a Large Cohort of Patients With Primary Ciliary Dyskinesia","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":451,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Primary ciliary dyskinesia; Heterotaxy; Situs inversus; Medicine; Dextrocardia; Cilium; Kartagener Syndrome; Heart disease; Ciliopathy; Internal medicine; Cardiology; Pathology; Bronchiectasis; Genetics; Biology; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.008018658565757406,"gpt":0.2608083696642429,"spread":0.2527897110984855,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000191378,0.00007339837,0.0001525229,0.0001248091,0.0000184807,0.000004891289,0.00001792571,0.00002787974,0.00002720642],"category_scores_gemma":[0.0001065921,0.00006186848,0.00001937228,0.0001600354,0.00006145345,0.00009669193,0.00001462093,0.00006223755,0.000002580069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006967191,"about_ca_system_score_gemma":0.00004423552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001701083,"about_ca_topic_score_gemma":0.00003533202,"domain_scores_codex":[0.999167,0.00002304509,0.0001637696,0.0001632341,0.0003110391,0.0001719312],"domain_scores_gemma":[0.9995661,0.00006201889,0.00004151607,0.000132716,0.00007903851,0.000118589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001055792,0.0001745546,0.9943008,0.0001590578,0.00001479139,0.00001082298,0.00004302373,0.00001043609,0.00392557,0.0000153781,0.000004665475,0.0002851533],"study_design_scores_gemma":[0.002039294,0.0001032622,0.9972968,0.00008061802,0.00002716728,0.000002698718,0.000006489721,0.0001670263,0.0001119991,0.00003937188,0.00006459589,0.00006066234],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980737,0.0002000343,0.0007156879,0.00001917372,0.0000143719,0.0007584025,0.00001962168,0.0000130134,0.0001859809],"genre_scores_gemma":[0.9994968,0.000001112959,0.0002663606,0.0001097531,0.00001879515,0.00001284998,0.00007650557,0.00001324883,0.000004632256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003813571,"threshold_uncertainty_score":0.2522923,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142218173","doi":"10.1002/ppul.23304","title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review","year":2015,"lang":"en","type":"review","venue":"Pediatric Pulmonology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McGill University; University of Toronto; Montreal Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Hospital for Sick Children; National Institutes of Health; Rare Diseases Clinical Research Network; Case Western Reserve University; NIH Clinical Center; Washington University in St. Louis; National Center for Advancing Translational Sciences; Children's Hospital Colorado; Georgia Clinical and Translational Science Alliance; Seattle Children's Research Institute; U.S. Public Health Service; Children's Hospital of Philadelphia","keywords":"Primary ciliary dyskinesia; Medicine; Consensus conference; Intensive care medicine; Disease; Diagnostic test; Lung disease; Pediatrics; Pathology; Bronchiectasis; Lung; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07266815401320091,"gpt":0.3813420170591401,"spread":0.3086738630459391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004644795,0.0003505011,0.00210541,0.0003743474,0.00005199032,0.000005637548,0.0001688577,0.0001547004,0.00005061576],"category_scores_gemma":[0.001618885,0.0002212868,0.0002801424,0.0006423115,0.0002298979,0.000030019,0.00007897677,0.0002655903,0.00002614386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004966686,"about_ca_system_score_gemma":0.001452721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002692374,"about_ca_topic_score_gemma":0.000004423932,"domain_scores_codex":[0.9973632,0.0005539309,0.001000095,0.000424518,0.0003779567,0.0002802693],"domain_scores_gemma":[0.9955893,0.002327689,0.0009154665,0.0007214728,0.0003111162,0.000134986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005195152,0.0004018272,0.003351436,0.03630576,0.00007891746,0.00001283279,0.000006908292,0.000001062799,5.751804e-7,0.000003039605,0.00509593,0.9546897],"study_design_scores_gemma":[0.0006029807,0.001028572,0.002350713,0.01051732,0.002309398,0.00005967189,0.000002149801,0.000006199196,0.000004290242,0.00004248214,0.9829238,0.0001524475],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00012724,0.9948693,0.000008092084,0.001719183,0.0004566313,0.002322013,0.0002209607,0.00002011418,0.0002564871],"genre_scores_gemma":[0.00003697445,0.9973729,0.001042175,0.00002746934,0.0002442163,0.0006868386,0.0003223845,0.00003503513,0.0002319554],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9778278,"threshold_uncertainty_score":0.9023814,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146555387","doi":"10.1210/jc.2004-1629","title":"Guide to Bone Health and Disease in Cystic Fibrosis","year":2005,"lang":"en","type":"review","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":445,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Cystic fibrosis; Medicine; Disease; Population; Bone disease; Bone health; Pediatrics; Osteoporosis; Intensive care medicine; Internal medicine; Bone mineral; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.09014182715806451,"gpt":0.5036404430051087,"spread":0.4134986158470442,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004106086,0.0004610997,0.006052563,0.0007041783,0.00007996349,0.00002145673,0.0006027765,0.0001875505,0.00009072788],"category_scores_gemma":[0.02347013,0.000257212,0.0008765718,0.000504427,0.0005451038,0.0001029842,0.0003651589,0.002694281,0.00007312728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001255573,"about_ca_system_score_gemma":0.003459058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005627462,"about_ca_topic_score_gemma":0.00002365127,"domain_scores_codex":[0.9905928,0.002564831,0.004800843,0.0004102083,0.0007291207,0.0009021426],"domain_scores_gemma":[0.989442,0.005587766,0.001740863,0.0007565381,0.0002433847,0.002229485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001208068,0.0002300405,0.00008861452,0.00217371,0.0002212041,0.0003410893,0.00003885916,0.00000526439,4.67533e-7,0.0001545641,0.007397138,0.988141],"study_design_scores_gemma":[0.001904931,0.0007847202,0.002026476,0.008214108,0.001380206,0.001681858,0.00002416024,0.000003498951,1.538859e-7,0.0001947382,0.9836143,0.0001708351],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003366157,0.9840164,0.00009490283,0.01382686,0.0005663228,0.001042978,0.00003806828,0.00001401275,0.00006385196],"genre_scores_gemma":[0.00004395053,0.9875785,0.006791836,0.002501702,0.002268597,0.00003595817,0.000008136304,0.00005807226,0.0007132479],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9879702,"threshold_uncertainty_score":0.999988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2210324311","doi":"10.1136/thoraxjnl-2015-207488","title":"International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety","year":2015,"lang":"en","type":"article","venue":"Thorax","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Anxiety; Psychological intervention; Mental health; Population; Guideline; Psychiatry; Depression (economics); Family medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04254065115875329,"gpt":0.3776714362008304,"spread":0.3351307850420771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001372692,0.0002962573,0.0004415584,0.0001657572,0.0003148096,0.0001649077,0.00009816882,0.00006551036,0.0000135938],"category_scores_gemma":[0.0008196752,0.0002690813,0.00005839959,0.0001793456,0.0002241097,0.0002572601,0.0002212235,0.0002412369,0.000004354089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003098441,"about_ca_system_score_gemma":0.00009558999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000218347,"about_ca_topic_score_gemma":0.0000407023,"domain_scores_codex":[0.9975289,0.0003142447,0.0005551907,0.0006096633,0.0005116698,0.0004803905],"domain_scores_gemma":[0.9982731,0.0007095058,0.0002355572,0.0002212908,0.0001392744,0.0004212433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0147122,0.0006360325,0.2339487,0.002868958,0.000410375,0.00002922033,0.009196968,0.0005909567,0.06059305,0.0001565845,0.01388547,0.6629715],"study_design_scores_gemma":[0.05437493,0.01191434,0.5595831,0.01647662,0.000460739,0.0006607173,0.01479241,0.2861512,0.004281288,0.001847074,0.0474666,0.00199095],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821908,0.002331521,0.009384028,0.002777725,0.0001835838,0.001976274,0.0005352704,0.0001089887,0.000511767],"genre_scores_gemma":[0.892257,0.0004392853,0.1061345,0.0002190641,0.0001160016,0.00007701865,0.000568538,0.0000547252,0.0001338357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6609806,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999664569","doi":"10.1016/s1569-1993(11)60014-3","title":"Recommendations for the classification of diseases as CFTR-related disorders","year":2011,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital; Mount Sinai Hospital; University of Toronto","funders":"European Commission","keywords":"Medicine; Cystic fibrosis; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04194855652784866,"gpt":0.3329156405862668,"spread":0.2909670840584181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003617651,0.0001061738,0.0002929207,0.0001741212,0.0001047914,0.000013037,0.000202703,0.00005083652,0.0003841269],"category_scores_gemma":[0.002664143,0.0000663729,0.0002597977,0.0002823608,0.0001973525,0.000177572,0.00002448963,0.0001719005,0.000009834446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006399964,"about_ca_system_score_gemma":0.0002179623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002935938,"about_ca_topic_score_gemma":0.00000492884,"domain_scores_codex":[0.9985926,0.00006214922,0.0006698156,0.0001079734,0.0003834445,0.0001840037],"domain_scores_gemma":[0.9972026,0.001377915,0.0005456391,0.0002500566,0.0004723241,0.0001515106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02333262,0.004416766,0.04167055,0.002020369,0.003323361,0.00001846554,0.006132934,0.000205767,0.2940792,0.01890898,0.1278434,0.4780475],"study_design_scores_gemma":[0.006252257,0.007066478,0.8384967,0.001360424,0.00224928,0.0002069571,0.003805856,0.003266125,0.008860126,0.03237001,0.09575795,0.0003078006],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6451037,0.02850587,0.2371137,0.06862886,0.004200915,0.006439218,0.0008618482,0.0001655348,0.008980333],"genre_scores_gemma":[0.9699839,0.0003192861,0.02915333,0.00004595679,0.00007949574,0.00002829766,0.0000167621,0.00002076659,0.0003522159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7968262,"threshold_uncertainty_score":0.420592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560738370","doi":"10.1164/rccm.201605-1027oc","title":"Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis","year":2017,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Bayer HealthCare; Tenovus; Wellcome Trust; Alere; Cystic Fibrosis Foundation Therapeutics; GlaxoSmithKline; Queen's University Belfast; AstraZeneca; Queen's University; European Respiratory Society; Pfizer","keywords":"Bronchiectasis; Medicine; Sputum; Internal medicine; Desmosine; Neutrophil elastase; Gastroenterology; Pulmonary function testing; Elastase; Exacerbation; Prospective cohort study; Lung; Pathology; Elastin; Tuberculosis","retraction":null,"screen_n_in":null,"score":{"opus":0.02135829084167652,"gpt":0.3513376159056967,"spread":0.3299793250640202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004772897,0.0001413625,0.0005492314,0.0002021954,0.0002254251,0.00003518369,0.00008091419,0.00004006669,0.00004622342],"category_scores_gemma":[0.004489098,0.00009629258,0.00003599852,0.0001662259,0.002011419,0.0002721439,0.00005097998,0.0004861501,2.80772e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009622933,"about_ca_system_score_gemma":0.0001614197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000911251,"about_ca_topic_score_gemma":0.0001335362,"domain_scores_codex":[0.9986108,0.000148749,0.0002981686,0.0001966172,0.0005094304,0.0002362597],"domain_scores_gemma":[0.9980183,0.0006334183,0.0002260701,0.0002176738,0.0004994391,0.0004051367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007218572,0.0002848061,0.6231508,0.00034125,0.0002071405,0.001118535,0.001115759,0.000003929041,0.01759593,0.0002042226,0.0006342215,0.3481248],"study_design_scores_gemma":[0.004801649,0.01892298,0.968975,0.001207407,0.0003968936,0.0002217153,0.002924522,0.00006343846,0.0004642942,0.00009930464,0.001783389,0.0001394205],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862438,0.003657666,0.0004879092,0.009238751,0.00005647416,0.0001153257,0.00001380844,0.00000662815,0.0001795705],"genre_scores_gemma":[0.9982129,0.0001438177,0.0002162465,0.001178602,0.0002209202,0.000004178716,0.000001522257,0.00001355374,0.00000822436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3479854,"threshold_uncertainty_score":0.7411155,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982956224","doi":"10.1126/science.1191542","title":"Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane","year":2010,"lang":"en","type":"article","venue":"Science","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; U.S. Public Health Service","keywords":"Endoplasmic reticulum; Cell biology; Ubiquitin; Cystic fibrosis transmembrane conductance regulator; Endoplasmic-reticulum-associated protein degradation; Membrane protein; Transmembrane protein; Chemistry; Unfolded protein response; Internalization; Protein degradation; Biochemistry; Biology; Cell; Membrane","retraction":null,"screen_n_in":null,"score":{"opus":0.01810607516728455,"gpt":0.3352677994669267,"spread":0.3171617242996422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001538963,0.0001082975,0.0001977838,0.0000413796,0.0003189692,0.0001226802,0.0005689191,0.00003977036,0.0003908583],"category_scores_gemma":[0.006288937,0.00006230016,0.00005115122,0.0004941605,0.001934768,0.0002735874,0.00008592403,0.0004106666,0.00006828988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004994738,"about_ca_system_score_gemma":0.0005185405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004673007,"about_ca_topic_score_gemma":0.0003434447,"domain_scores_codex":[0.9977419,0.00007220043,0.000210428,0.0003969697,0.001144241,0.0004342369],"domain_scores_gemma":[0.9983544,0.0004572972,0.00006898284,0.0006765301,0.0002018263,0.0002410108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002111588,0.00003359223,0.004631417,0.00001026162,0.000005419834,0.000006081033,0.0002032415,0.000002443896,0.9866015,0.0007421666,0.00006756864,0.007485101],"study_design_scores_gemma":[0.003533346,0.000286146,0.5332882,0.0001237552,0.00001828029,0.00003131849,0.0005212253,0.005091829,0.4316667,0.004182467,0.02100542,0.0002513235],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991183,0.0000835469,0.000184091,0.005867498,0.0002931617,0.0006880809,0.00003013691,0.00005528073,0.001615209],"genre_scores_gemma":[0.9909331,0.000002408261,0.007785428,0.0003794212,0.00020465,0.00003813801,0.000002629298,0.000007361161,0.0006468206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5549349,"threshold_uncertainty_score":0.7528899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2262352079","doi":"10.1038/srep10241","title":"Lung microbiota across age and disease stage in cystic fibrosis","year":2015,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; St. Michael's Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Cystic Fibrosis Canada; National Sanitarium Association","keywords":"Cystic fibrosis; Biology; Prevotella; Veillonella; Actinomyces; Stenotrophomonas; Lung; Fusobacterium; Burkholderia cepacia complex; Burkholderia; Streptococcus; Microbiology; Pseudomonas; Medicine; Internal medicine; Bacteria; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02283793007651026,"gpt":0.3366200196633862,"spread":0.313782089586876,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00163369,0.0001489714,0.0002676416,0.0001800337,0.0001319402,0.0003159402,0.00008276428,0.00004395048,0.00007024768],"category_scores_gemma":[0.002974422,0.0001268053,0.00005276006,0.0005874946,0.0006031839,0.0002209086,0.000209487,0.0001610704,0.00002074175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001768496,"about_ca_system_score_gemma":0.0004931788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009071773,"about_ca_topic_score_gemma":0.00007800473,"domain_scores_codex":[0.9975091,0.00005008429,0.000429474,0.0007894547,0.0006758553,0.0005460872],"domain_scores_gemma":[0.9978112,0.00006160469,0.0001141818,0.0008223014,0.000161345,0.001029384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008218526,0.00046721,0.5237888,0.001196974,0.0000346094,0.04737259,0.002637615,0.0001632336,0.3397807,0.00003978896,0.07935812,0.004338573],"study_design_scores_gemma":[0.003861443,0.000333355,0.5141478,0.001615657,0.0001004057,0.001444817,0.001820245,0.002416359,0.01771317,0.00623845,0.4494013,0.0009070451],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946805,0.002440549,0.0001273107,0.0003501226,0.001347759,0.0006141434,0.00003479315,0.00005204926,0.0003527956],"genre_scores_gemma":[0.9832463,0.000006053072,0.002344772,0.00003463585,0.00004583505,0.00004219812,0.0001125317,0.0000196929,0.01414804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3700432,"threshold_uncertainty_score":0.5170971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151837778","doi":"10.1038/nchembio.1253","title":"Mechanism-based corrector combination restores ΔF508-CFTR folding and function","year":2013,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":390,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences","keywords":"Cystic fibrosis transmembrane conductance regulator; ΔF508; Cystic fibrosis; Cyclic nucleotide-binding domain; Missense mutation; Chemistry; Mutation; Cell biology; Membrane biology; Biology; Genetics; Biochemistry; Membrane; Peptide sequence; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.008943560265077147,"gpt":0.2906508558577904,"spread":0.2817072955927132,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001061817,0.0001177448,0.0002097592,0.00009530976,0.00004160525,0.00001397326,0.00006320966,0.0004439295,0.0002540819],"category_scores_gemma":[0.001333946,0.0000892961,0.00003961028,0.0001396635,0.0001356905,0.00005712882,0.00004261962,0.0005630343,0.00003348153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008557898,"about_ca_system_score_gemma":0.00003937582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002383042,"about_ca_topic_score_gemma":0.000002017752,"domain_scores_codex":[0.9991357,0.00003966057,0.0001411889,0.0002963236,0.0001414469,0.0002457048],"domain_scores_gemma":[0.9991171,0.00037468,0.00004708791,0.0001475128,0.0001734269,0.0001401899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002409203,0.00005167009,0.002758006,0.00005155279,0.000015608,0.000001553458,0.000006217098,8.9408e-8,0.980881,0.003497588,0.002502627,0.009993197],"study_design_scores_gemma":[0.002420841,0.0009150181,0.01388541,0.00009472015,0.00003951209,0.00002688664,0.00002863703,0.001647363,0.9490355,0.01930684,0.01241618,0.0001831272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939916,0.00143969,0.001069942,0.002248975,0.0003611641,0.000414047,0.000006819034,0.00009218753,0.0003756163],"genre_scores_gemma":[0.995613,0.00002088931,0.003164052,0.0007468015,0.0001444912,0.00005418649,0.0001575043,0.00001241676,0.00008662129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03184551,"threshold_uncertainty_score":0.3641389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560723352","doi":"10.1186/s12890-016-0339-5","title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","year":2016,"lang":"en","type":"review","venue":"BMC Pulmonary Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Research Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Research Manitoba","keywords":"Cystic fibrosis; Pseudomonas aeruginosa; Medicine; Disease; Lung; Lung disease; Lung infection; Intensive care medicine; Immunology; Biology; Pathology; Genetics; Internal medicine; Bacteria","retraction":null,"screen_n_in":null,"score":{"opus":0.03380949016526695,"gpt":0.3424020245398755,"spread":0.3085925343746085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007303734,0.0008640664,0.002884589,0.000676862,0.0001622296,0.0000184486,0.0002019848,0.0004174428,0.001346184],"category_scores_gemma":[0.001065719,0.0005181097,0.0003700102,0.0003812274,0.0007998941,0.0001640305,0.0002927248,0.0006793026,0.0003779487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006377825,"about_ca_system_score_gemma":0.0003870219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008509322,"about_ca_topic_score_gemma":0.000003538077,"domain_scores_codex":[0.9954982,0.0003615421,0.001120973,0.001118831,0.00113365,0.0007667506],"domain_scores_gemma":[0.996109,0.001679574,0.0004321126,0.000966648,0.00006334788,0.0007492997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001868984,0.0001169301,0.0007318034,0.05303291,0.0001820269,0.0003166728,0.00001717238,3.310562e-7,0.000145693,0.00004915602,0.002712523,0.9425079],"study_design_scores_gemma":[0.0009348633,0.0006988558,0.001424209,0.07117688,0.001650816,0.002887068,0.000009379798,0.00006250368,0.000002749116,0.00007089163,0.9206349,0.0004469221],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003396669,0.9932847,0.001718899,0.0002728424,0.0003929982,0.002348903,0.0000860618,0.0001351922,0.001726448],"genre_scores_gemma":[0.00009440164,0.9914455,0.001719235,0.00004354603,0.001707744,0.0004635813,0.0004211345,0.0001398156,0.003965029],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9420609,"threshold_uncertainty_score":0.9997271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151640544","doi":"10.1086/676882","title":"Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update","year":2014,"lang":"en","type":"article","venue":"Infection Control and Hospital Epidemiology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Cystic Fibrosis Foundation","keywords":"Infection control; Guideline; Medicine; Health care; Intensive care medicine; Population; Transmission (telecommunications); Public health; Environmental health; Nursing; Pathology; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.01363365223587542,"gpt":0.3348445519066617,"spread":0.3212108996707863,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002218963,0.0002189489,0.0007698727,0.0001647599,0.0001852543,0.00002120827,0.00002821304,0.0002035964,0.00003537013],"category_scores_gemma":[0.008564693,0.0001797479,0.0001473728,0.0000846659,0.0002236661,0.0002109441,0.00002474847,0.0002068996,0.00001916603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005058468,"about_ca_system_score_gemma":0.00003607975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006644421,"about_ca_topic_score_gemma":0.0001495682,"domain_scores_codex":[0.9978513,0.0004215642,0.0007380189,0.0004657974,0.0000955905,0.000427756],"domain_scores_gemma":[0.9969115,0.00207863,0.0002821363,0.000186442,0.0003006631,0.0002405793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004179513,0.0004768247,0.5804926,0.0008352401,0.0006602637,0.000002614694,0.00004789801,0.001228855,0.01256804,0.01066212,0.03030297,0.3585431],"study_design_scores_gemma":[0.01244271,0.007730601,0.595664,0.0001253601,0.0003688016,0.00009304741,0.000005086474,0.1139462,0.00004776709,0.02488903,0.2444018,0.0002855983],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.1814233,0.002339869,0.7972422,0.01657893,0.0005444412,0.001615653,0.00003822555,0.0001346871,0.00008269192],"genre_scores_gemma":[0.9899606,0.0009619596,0.00592585,0.001992227,0.0005443424,0.000404706,0.0000853532,0.00002320065,0.0001018369],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8085372,"threshold_uncertainty_score":0.9997866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058169488","doi":"10.1016/j.molmed.2011.10.003","title":"CFTR: folding, misfolding and correcting the ΔF508 conformational defect","year":2011,"lang":"en","type":"review","venue":"Trends in Molecular Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":382,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; Canada Research Chairs; Health Canada; Cystic Fibrosis Foundation Therapeutics; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Proteostasis; ΔF508; Cystic fibrosis transmembrane conductance regulator; Chloride channel; Endocytic cycle; Cystic fibrosis; Potentiator; Cell biology; Mutation; Protein folding; Mutant; Population; Membrane protein; Chemistry; Biology; Genetics; Biochemistry; Medicine; Endocytosis; Membrane; Gene; Cell","retraction":null,"screen_n_in":null,"score":{"opus":0.07343633307036355,"gpt":0.409041695068347,"spread":0.3356053619979834,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001225658,0.0004967503,0.001766196,0.0009236304,0.0001109114,0.0000223342,0.0002917934,0.0002186243,0.0006147997],"category_scores_gemma":[0.001553542,0.0002876896,0.0003274871,0.0009987168,0.0004524881,0.00007322316,0.0001671266,0.00106505,0.0000197914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001837246,"about_ca_system_score_gemma":0.0001688029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001014375,"about_ca_topic_score_gemma":0.00002097185,"domain_scores_codex":[0.9971488,0.0002467138,0.0009012733,0.0004899349,0.0006686847,0.0005445522],"domain_scores_gemma":[0.9980107,0.0007546531,0.0003556763,0.0005563202,0.00008663724,0.000236026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002629457,0.00002234093,0.00004126626,0.004068464,0.0001821462,0.0001630074,0.0002968029,4.552074e-7,0.00002099792,0.0003873587,0.0008292514,0.9939616],"study_design_scores_gemma":[0.001270426,0.0003952751,0.0001699046,0.02888233,0.001107636,0.002231375,0.0001519852,0.0000570271,0.00001362187,0.00008032226,0.9653509,0.0002891521],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008129871,0.9896691,0.0004288903,0.0002149772,0.0002750078,0.0005952044,0.00000915582,0.00004989334,0.008676509],"genre_scores_gemma":[0.0005442623,0.9967062,0.001196433,0.0002010652,0.0002569415,0.0001415814,0.0002210397,0.00007588172,0.0006565892],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9936725,"threshold_uncertainty_score":0.9999575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3184730432","doi":"10.1038/s41436-021-01203-z","title":"Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)","year":2021,"lang":"en","type":"article","venue":"Genetics in Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"North York General Hospital; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Carrier testing; Medical genetics; Population; Medicine; Newborn screening; Family medicine; Pregnancy; Genetics; Prenatal diagnosis; Pediatrics; Biology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.0325932106346259,"gpt":0.3697737160766313,"spread":0.3371805054420055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003741534,0.0001292953,0.0004818933,0.00009931103,0.00008871599,0.00000506056,0.0001138401,0.00007885783,0.00002301517],"category_scores_gemma":[0.004730989,0.0001016976,0.00002682071,0.0003324094,0.001613172,0.00003229452,0.0002375475,0.0002578268,3.959595e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003156214,"about_ca_system_score_gemma":0.0002309457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001702055,"about_ca_topic_score_gemma":0.00007262459,"domain_scores_codex":[0.9982457,0.0001548077,0.0005030828,0.0003108751,0.0005652204,0.0002203825],"domain_scores_gemma":[0.9976788,0.001282027,0.0003032981,0.0002914181,0.000259821,0.0001846101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003457317,0.0006849689,0.226773,0.00809723,0.0008324352,0.0005396722,0.01127928,0.0004544322,0.6211346,0.002685463,0.0007513096,0.1233102],"study_design_scores_gemma":[0.01888236,0.003433041,0.8425431,0.01387798,0.0008024827,0.002446501,0.03353588,0.01964371,0.05249965,0.001216103,0.01069581,0.0004234183],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9650579,0.02545943,0.0009048568,0.007580034,0.00004200477,0.000713603,0.0001255103,0.000006749523,0.0001099303],"genre_scores_gemma":[0.9369151,0.01653445,0.04602367,0.0001909893,0.000145255,0.00004575102,0.00002086278,0.00002378585,0.0001001073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.61577,"threshold_uncertainty_score":0.5943798,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3214022819","doi":"10.1164/rccm.202108-1986oc","title":"Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial","year":2021,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Cystic Fibrosis Foundation","keywords":"Ivacaftor; Cystic fibrosis; Clinical trial; Population; Medical prescription; Confidence interval; Body mass index; Observational study","retraction":null,"screen_n_in":null,"score":{"opus":0.03500884647025019,"gpt":0.4265651785884598,"spread":0.3915563321182096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.004309997,0.0002760452,0.002399405,0.0002847644,0.00005202108,0.00001469496,0.0001880358,0.000140611,0.00008782018],"category_scores_gemma":[0.02188802,0.0001872355,0.0002887928,0.0008557818,0.003298229,0.0001574921,0.00008603018,0.001219031,0.000001640644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001117467,"about_ca_system_score_gemma":0.001380765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002943898,"about_ca_topic_score_gemma":0.000006117188,"domain_scores_codex":[0.9932977,0.002586332,0.002048796,0.0004893324,0.001128028,0.0004497985],"domain_scores_gemma":[0.9861079,0.01045948,0.0004563539,0.0004131768,0.001682968,0.0008800907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.191019,0.001042133,0.7263433,0.001827725,0.0002354069,0.002415681,0.00009545185,0.000003205081,0.004169748,0.0002887569,0.0001283789,0.07243121],"study_design_scores_gemma":[0.07111374,0.1238455,0.7848921,0.006191888,0.0007053855,0.0007547247,0.007204565,0.000009624036,0.0008352932,0.0001107312,0.004059477,0.0002769699],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873945,0.01083734,0.000793771,0.0002863367,0.000127739,0.0003697973,0.0000119075,0.00001043858,0.0001682444],"genre_scores_gemma":[0.9951928,0.0002804124,0.002869172,0.0005244699,0.001072782,0.00001629788,0.000004523325,0.00003290723,0.000006608765],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1228034,"threshold_uncertainty_score":0.9994142,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132211475","doi":"10.1099/jmm.0.45969-0","title":"Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung","year":2005,"lang":"en","type":"article","venue":"Journal of Medical Microbiology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":370,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Guelph","funders":"University of Pittsburgh","keywords":"Pseudomonas aeruginosa; Sputum; Cystic fibrosis; Microbiology; Biofilm; Biology; Lung; Chronic infection; Bacteria; Medicine; Immunology; Pathology; Tuberculosis; Internal medicine; Genetics; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.02288458413534656,"gpt":0.3235291818474951,"spread":0.3006445977121486,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001386805,0.0001531285,0.0005768295,0.0001848404,0.00008080025,0.00001054761,0.0004773813,0.0002408744,0.000203309],"category_scores_gemma":[0.002180108,0.0000882403,0.0002987781,0.0001636107,0.0004533013,0.0001217395,0.0001009648,0.0005141707,0.000006663735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001454485,"about_ca_system_score_gemma":0.0006127922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006714719,"about_ca_topic_score_gemma":0.00001156803,"domain_scores_codex":[0.9980407,0.00005639742,0.0009763313,0.0001402375,0.0004001511,0.0003861566],"domain_scores_gemma":[0.9970342,0.001518009,0.0004974264,0.0002052434,0.0004911204,0.0002540281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001320184,0.0002620653,0.00005234338,0.0002831033,0.0001671027,0.000006436372,0.0001894026,0.0005174174,0.9579353,0.0001787805,0.02648567,0.01260223],"study_design_scores_gemma":[0.02361561,0.004339887,0.000604703,0.002140756,0.0009225206,0.01673188,0.0005843351,0.3945867,0.320244,0.0003393518,0.2354393,0.0004510683],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2966261,0.00977191,0.6171958,0.07430442,0.000458073,0.001297887,0.0002602231,0.00001934424,0.00006620929],"genre_scores_gemma":[0.8214832,0.0007701396,0.1747438,0.001798732,0.0009325427,0.00003573562,0.00002807302,0.00002604715,0.000181722],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6376913,"threshold_uncertainty_score":0.3598335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052470792","doi":"10.1136/thx.2007.077784","title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","year":2007,"lang":"en","type":"article","venue":"Thorax","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"British Columbia Lung Association","keywords":"Medicine; Spirometry; Cystic fibrosis; Lung disease; Lung; Lung function; Washout; Inert gas; Pathology; Cardiology; Intensive care medicine; Internal medicine; Asthma","retraction":null,"screen_n_in":null,"score":{"opus":0.0170929177473397,"gpt":0.3397560273916156,"spread":0.3226631096442759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000338289,0.0002076761,0.0003264192,0.0003539553,0.00006853265,0.00003331665,0.0001079491,0.0000663324,0.0001387717],"category_scores_gemma":[0.001805672,0.0001720442,0.00005832639,0.0004954956,0.0001793183,0.0001569882,0.0001207305,0.0002805171,0.00001898704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002141517,"about_ca_system_score_gemma":0.00007745411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000189364,"about_ca_topic_score_gemma":0.0001398631,"domain_scores_codex":[0.9982348,0.00004307042,0.0002944006,0.0003765689,0.0004797235,0.0005714132],"domain_scores_gemma":[0.9982654,0.0007083836,0.00004771937,0.0003421341,0.00006065445,0.0005757185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01318925,0.00007668506,0.9320942,0.000515967,0.00004389674,0.0005754366,0.0002065694,0.00003423641,0.02087122,0.0000901669,0.0002208273,0.03208156],"study_design_scores_gemma":[0.004904137,0.0003237848,0.9850594,0.0002903572,0.00007619922,0.00002686728,0.0001511788,0.006002895,0.002144376,0.0001317499,0.0006635644,0.0002254977],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954093,0.002798393,0.0003386571,0.0002631418,0.0001761989,0.0004702429,0.00004163309,0.00006851013,0.0004338991],"genre_scores_gemma":[0.9944074,0.00006143339,0.004977114,0.00003950215,0.0001837628,0.0000186205,0.00006089374,0.00003125341,0.000219981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05296522,"threshold_uncertainty_score":0.7015761,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996779865","doi":"10.1038/nsmb882","title":"The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR","year":2004,"lang":"en","type":"article","venue":"Nature Structural & Molecular Biology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Cyclic nucleotide-binding domain; Cystic fibrosis transmembrane conductance regulator; Chemistry; ΔF508; Endoplasmic reticulum; Transmembrane domain; Folding (DSP implementation); Protein folding; Mutagenesis; Mutant; Biochemistry; Transmembrane protein; Mutation; Biophysics; Amino acid; Cell biology; Peptide sequence; Biology; Gene; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.003456809102838618,"gpt":0.3237522831019178,"spread":0.3202954739990792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001404367,0.0001726491,0.0002387007,0.0001344728,0.0001989495,0.00002156226,0.0001176864,0.0001945386,0.00002088122],"category_scores_gemma":[0.0005755375,0.0001139739,0.0001134433,0.0002328423,0.0003961737,0.00007765127,0.0000469636,0.0005549632,0.000001659852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007851977,"about_ca_system_score_gemma":0.0001250135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000615779,"about_ca_topic_score_gemma":0.0001042066,"domain_scores_codex":[0.9987612,0.0001121946,0.0002877311,0.0002913545,0.0002425917,0.0003049044],"domain_scores_gemma":[0.999024,0.0003128544,0.000116377,0.0002041813,0.000233583,0.0001089509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005743084,0.000009044291,0.0009064588,0.00004935676,0.0001109944,0.00003350546,0.0002058722,0.0001195814,0.9681231,0.02595066,0.00001178816,0.003905356],"study_design_scores_gemma":[0.006821698,0.00237716,0.394685,0.0003946078,0.0002105329,0.002828154,0.001200902,0.0003277564,0.1975544,0.3888923,0.004118476,0.0005890136],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836042,0.004195902,0.006156462,0.005147154,0.0002781641,0.000450039,0.00007919956,0.00002570217,0.00006317412],"genre_scores_gemma":[0.9682199,0.00001761067,0.03126924,0.0001699824,0.00007864933,0.00001614747,0.0002062464,0.00001575376,0.000006499587],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7705687,"threshold_uncertainty_score":0.464772,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165913026","doi":"10.1101/gr.086082.108","title":"Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of <i>Pseudomonas aeruginosa</i>","year":2008,"lang":"en","type":"article","venue":"Genome Research","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Université Laval; Simon Fraser University","funders":"Canadian Institutes of Health Research; Cystic Fibrosis Trust; Michael Smith Health Research BC; Wellcome Trust","keywords":"Prophage; Biology; Genetics; Genome; Genomic island; Gene; Pseudomonas aeruginosa; Strain (injury); Whole genome sequencing; Bacteriophage; Microbiology; Bacteria; Escherichia coli","retraction":null,"screen_n_in":null,"score":{"opus":0.06793628400722844,"gpt":0.3851347371039215,"spread":0.3171984530966931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003959897,0.0001965374,0.0008117741,0.0008063677,0.0001037534,0.00001239189,0.0006550123,0.0001198047,0.0002634294],"category_scores_gemma":[0.003719899,0.0001481289,0.0001064399,0.001261807,0.002184886,0.0001146888,0.0002658313,0.0009790525,0.00002472735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002603413,"about_ca_system_score_gemma":0.0007540431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000351921,"about_ca_topic_score_gemma":0.000264571,"domain_scores_codex":[0.9950327,0.001199654,0.0008043853,0.0005180174,0.001449093,0.0009961145],"domain_scores_gemma":[0.9958245,0.002707296,0.000102883,0.0006931528,0.0004944346,0.0001777856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001287392,0.0006701516,0.2411483,0.001244489,0.00001747632,0.001412255,0.002570958,0.00003713716,0.7501652,0.0002165063,0.00005362671,0.001176573],"study_design_scores_gemma":[0.003062363,0.00134314,0.9457663,0.0007304896,0.00001102774,0.0003684487,0.002926702,0.0005468949,0.04432122,0.0003660427,0.0003676376,0.0001896958],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954553,0.001594658,0.00007178156,0.0006364528,0.00003030864,0.001359375,0.0001892013,0.000008600291,0.0006542746],"genre_scores_gemma":[0.9979797,0.0006932043,0.0008657256,0.00003319663,0.0001248015,0.0001176783,0.00001140901,0.00002515226,0.0001491194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7058439,"threshold_uncertainty_score":0.8050303,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128677706","doi":"10.1001/jama.2010.563","title":"Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With &lt;emph type=\"ital\"&gt;Pseudomonas aeruginosa&lt;/emph&gt;&lt;subtitle&gt;A Randomized Controlled Trial&lt;/subtitle&gt;","year":2010,"lang":"en","type":"article","venue":"JAMA","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Centers for Disease Control and Prevention; National Institutes of Health; National Center for Research Resources; Cystic Fibrosis Foundation Therapeutics; University of Washington; Gilead Sciences; Pfizer; Cystic Fibrosis Foundation","keywords":"Medicine; Azithromycin; Placebo; Cystic fibrosis; Internal medicine; Pulmonary function testing; Randomization; Pseudomonas aeruginosa; Adverse effect; Randomized controlled trial; Gastroenterology; Antibiotics; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.004049976769511196,"gpt":0.2380534126547403,"spread":0.2340034358852291,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002607158,0.0009127395,0.003554207,0.0009452334,0.0001754869,0.0001176447,0.0003750208,0.000502184,0.0009862001],"category_scores_gemma":[0.007420775,0.0005735856,0.0004875239,0.001460598,0.0007028042,0.0004589392,0.0001234408,0.001041144,0.0002623608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003117955,"about_ca_system_score_gemma":0.0004922706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001141105,"about_ca_topic_score_gemma":0.0003043815,"domain_scores_codex":[0.9930342,0.001353527,0.001389946,0.00106844,0.002133628,0.001020213],"domain_scores_gemma":[0.9909632,0.005490367,0.0008241038,0.001226431,0.001004735,0.0004912005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8627449,0.001325472,0.005465421,0.00051994,0.0006716148,0.0001063224,0.00008040902,0.00007848469,0.1237701,0.000152917,0.0009614434,0.004123004],"study_design_scores_gemma":[0.9146653,0.02031648,0.04756105,0.001426767,0.001061617,0.00003658469,0.0000119957,0.001624519,0.01029302,0.00006811036,0.002257677,0.0006768105],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823298,0.0004240333,0.0001724815,0.0002364382,0.0008198423,0.01114491,0.00008150571,0.0002044959,0.004586468],"genre_scores_gemma":[0.9955742,0.00005495024,0.000799257,0.00007880491,0.0004120149,0.001009879,0.000466549,0.0001733794,0.001430979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1134771,"threshold_uncertainty_score":0.999927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126006315","doi":"10.1128/jcm.38.2.910-913.2000","title":"Diagnostically and Experimentally Useful Panel of Strains from the <i>Burkholderia cepacia</i> Complex","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Microbiology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":326,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Burkholderia cepacia complex; Burkholderia; Microbiology; Burkholderia cenocepacia; Biology; Virulence; Identification (biology); Bacteria; Genetics; Ecology","retraction":null,"screen_n_in":null,"score":{"opus":0.1146008820891161,"gpt":0.4135162218258648,"spread":0.2989153397367487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007717703,0.0001311449,0.0008413669,0.00003180442,0.00003690019,0.00001244389,0.0002421447,0.0001485023,0.002279446],"category_scores_gemma":[0.002267341,0.00007564553,0.0002374981,0.00006981172,0.001132394,0.00005483254,0.00006595923,0.0005275555,0.00002273136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001612955,"about_ca_system_score_gemma":0.000171183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000236342,"about_ca_topic_score_gemma":0.00001506749,"domain_scores_codex":[0.9977169,0.0003409485,0.001392476,0.000187657,0.0001189561,0.0002430804],"domain_scores_gemma":[0.9948625,0.004126743,0.0003876077,0.0002299334,0.0001727566,0.000220458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002008168,0.0005759447,0.04010339,0.00001644948,0.0002815929,0.00007909221,0.0001580805,0.000002630147,0.9311199,0.00003580456,0.008566532,0.01705242],"study_design_scores_gemma":[0.006005246,0.004547893,0.8751073,0.000272968,0.0001682821,0.0009286787,0.0003226059,0.00001608805,0.009689718,0.000516326,0.10229,0.0001348469],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938344,0.001467472,0.00005923724,0.003742059,0.0001712939,0.0001790293,0.0001337732,0.000004961222,0.0004077585],"genre_scores_gemma":[0.9902442,0.001482804,0.005910861,0.001796408,0.000456753,0.000001060405,0.00002137195,0.00001257629,0.0000739369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9214302,"threshold_uncertainty_score":0.9986326,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}